Skip to main content

Advertisement

Erratum to: Genetically-controlled Vesicle-Associated Membrane Protein 1 expression may contribute to Alzheimer’s pathophysiology and susceptibility

Article metrics

The original article was published in Molecular Neurodegeneration 2015 10:18

Erratum

Following publication of this work [1], we noticed that we inadvertently failed to include Dr Ferenc Deák in the author list. The author list has now been corrected and the amended authors’ contributions section has been modified accordingly below.

Reference

  1. 1.

    Daniel S, Fanggeng Z, Li M, Sebastian C, Crump MG, Culley OJ, et al. Genetically-controlled Vesicle-Associated Membrane Protein 1 expression may contribute to Alzheimer’s pathophysiology and susceptibility. Mol Neurodegener. 2015;10:18.

Download references

Author information

Correspondence to Olivia Belbin.

Additional information

Authors’ contributions

DS was responsible for generation and maintenance of the mouse models, shRNA knockdown and neuronal cultures, assisted in the data analysis and manuscript writing. FZ participated in the design of the study, was responsible for the TaqMan low-density array of VAMP1 transcripts, genotyping and assisted in the data analysis and manuscript writing. LM was responsible for the maintenance of the DNA samples, assisted in the genotyping and Aß ELISA. SC assisted in the generation and maintenance of the mouse models, shRNA knockdown and neuronal cultures. MC performed the genotyping and dual luciferase assay for rs7390. OJC performed the dual luciferase assay for rs12964 and rs2072376. TAH supervised the genotyping of VAMP1. GB assisted in the maintenance of the DNA samples and genotyping. LY and MA performed the Aß ELISA. MMC participated in the design of the study, assisted in the genotyping and data analysis. SBS and JOA provided DNA samples for the study. DWD, NRG-R and RP provided DNA samples for the study as well as clinical and postmortem diagnoses. FD played a key role in the conception and design of the study. KM for the ARUK consortium provided DNA samples for the study, participated in the design of the study. OB participated in the design of the study, supervised the dual luciferase assay, and was responsible for the data analysis and writing of the manuscript. All authors critically revised the manuscript, gave final approval for submission and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Daniel Sevlever and Fanggeng Zou contributed equally to this work.

The online version of the original article can be found under doi:10.1186/s13024-015-0015-x.

The online version of the original article can be found at http://dx.doi.org/10.1186/s13024-015-0015-x.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Sevlever, D., Zou, F., Ma, L. et al. Erratum to: Genetically-controlled Vesicle-Associated Membrane Protein 1 expression may contribute to Alzheimer’s pathophysiology and susceptibility. Mol Neurodegeneration 10, 49 (2015) doi:10.1186/s13024-015-0047-2

Download citation